Loading...
Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production
Lactobacillus casei strain Shirota was selected as a bacterial carrier for the development of live mucosal vaccines against coronavirus. A 75 kDa fragment of transmissible gastroenteritis coronavirus (TGEV) spike glycoprotein S was used as the model coronavirus antigen. The S glycoprotein was cloned...
Saved in:
| Published in: | Vaccine |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Elsevier Ltd.
2005
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7115493/ https://ncbi.nlm.nih.gov/pubmed/15661381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2004.09.015 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|